Clinical effects of unintentional pediatric buprenorphine exposures: experience at a single tertiary care center

References

• Rudd RA, Paulozzi LJ, Bauer MJ, et al. Increases in heroin overdose deaths – 28 States, 2010 to 2012. MMWR Morb Mortal Wkly Rep. 2014;63:849–854.
   PubMed Web of Science ®Google Scholar
• Jones CM. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers – United States, 2002–2004 and 2008–2010. Drug Alcohol Depend. 2013;132:95–100.
   PubMed Web of Science ®Google Scholar
• Jones CM. Frequency of prescription pain reliever nonmedical use: 2002–2003 and 2009–2010. Arch Intern Med. 2012;172:1265–1267.
   PubMed Web of Science ®Google Scholar
• Mattick RP, Breen C, Kimber J, et al. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2014;2:CD002207.
   PubMed Web of Science ®Google Scholar
• Kraus ML, Alford DP, Kotz MM, et al. Statement of the American Society of Addiction Medicine Consensus Panel on the use of buprenorphine in office-based treatment of opioid addiction. J Addict Med. 2011;5:254–263.
   PubMed Web of Science ®Google Scholar
• Orman JS, Keating GM, Renzelli CM, et al. Buprenorphine/naloxone: a review of its use in the treatment of opioid dependence. Drugs. 2009;69:577–607.
   PubMed Web of Science ®Google Scholar
• Walsh SL, Preston KL, Bigelow GE, et al. Acute administration of buprenorphine in humans: partial agonist and blockade effects. J Pharmacol Exp Ther. 1995;274:361–372.
   PubMed Web of Science ®Google Scholar
• Walsh SL, Preston KL, Stitzer ML, et al. Clinical pharmacology of buprenorphine: ceiling effects at high doses. Clin Pharmacol Ther. 1994;55:569–580.
   PubMed Web of Science ®Google Scholar
• Lee SC, Klein-Schwartz W, Doyon S, et al. Comparison of toxicity associated with nonmedical use of benzodiazepines with buprenorphine or methadone. Drug Alcohol Depend. 2014;138:118–123.
   PubMed Web of Science ®Google Scholar
• Dahan A, Yassen A, Romberg R, et al. Buprenorphine induces ceiling in respiratory depression but not in analgesia. Br J Anaesth. 2006;96:627–632.
   PubMed Web of Science ®Google Scholar
• Chiang C. Pharmacokinetics of the combination tablet of buprenorphine and naloxone. Drug Alcohol Depend. 2003;70:S39–S47.
   PubMed Web of Science ®Google Scholar
• Sporer K. Buprenorphine: a primer for emergency physicians. Ann Emerg Med. 2004;43:580–584.
   PubMed Web of Science ®Google Scholar
• Bellot B, Michel F, Thomachot L, et al. Acute leukoencephalopathy after buprenorphine intoxication in a 2-year-old child. Eur J Paediatr Neurol. 2011;15:368–371.
   PubMed Web of Science ®Google Scholar
• Geib A-J, Babu K, Ewald MB, et al. Adverse effects in children after unintentional buprenorphine exposure. Pediatrics. 2006;118:1746–1751.
   PubMed Web of Science ®Google Scholar
• Kim HK, Smiddy M, Hoffman RS, et al. Buprenorphine may not be as safe as you think: a pediatric fatality from unintentional exposure. Pediatrics. 2012;130:e1700–e1703.
   PubMedGoogle Scholar
• Lavonas EJ, Banner W, Bradt P, et al. Root causes, clinical effects, and outcomes of unintentional exposures to buprenorphine by young children. J Pediatr. 2013;163:1377–1383.e1–e3.
   PubMed Web of Science ®Google Scholar
• Hayes BD, Klein-Schwartz W, Doyon S. Toxicity of buprenorphine overdoses in children. Pediatrics. 2008;121:e782–e786.
   PubMed Web of Science ®Google Scholar
• Thomas KC, Malheiro M, Crouch B, et al. Buprenorphine prescribing practices and exposures reported to a poison center–Utah, 2002–2011. MMWR Morbidity Mortal Wkly Rep. 2012;61:997–1001.
   PubMedGoogle Scholar
• Lovegrove MC, Mathew J, Hampp C, et al. Emergency hospitalizations for unsupervised prescription medication ingestions by young children. Pediatrics. 2014;134:e1009–e1016.
   PubMed Web of Science ®Google Scholar
• Mark T, Kassed C, Vandivort-Warren R, et al. Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty. Drug Alcohol Depend. 2009;99:345–349.
   PubMed Web of Science ®Google Scholar
• Stein BD, Gordon AJ, Sorbero M, et al. The impact of buprenorphine on treatment of opioid dependence in a Medicaid population: recent service utilization trends in the use of buprenorphine and methadone. Drug Alcohol Depend. 2012;123:72–78.
   PubMed Web of Science ®Google Scholar
• Knudsen HK. The supply of physicians waivered to prescribe buprenorphine for opioid use disorders in the United States: a state-level analysis. J Stud Alcohol Drugs. 2015;76:644–654.
   PubMed Web of Science ®Google Scholar
• Kantor ED, Rehm CD, Haas JS, et al. Trends in prescription drug use among adults in the United States from 1999–2012. JAMA. 2015;314:1818.
   PubMed Web of Science ®Google Scholar
• Lovegrove MC, Weidle NJ, Budnitz DS. Trends in emergency department visits for unsupervised pediatric medication exposures, 2004–2013. Pediatrics. 2015;136:e821–e829.
   PubMed Web of Science ®Google Scholar
• Benson BE, Spyker DA, Troutman WG, et al. TESS-based dose-response using pediatric clonidine exposures. Toxicol Appl Pharmacol. 2006;213:145–151.
   PubMed Web of Science ®Google Scholar
• Fleming S, Thompson M, Stevens R, et al. Normal ranges of heart rate and respiratory rate in children from birth to 18 years of age: a systematic review of observational studies. Lancet. 2011;377:1011–1018.
   PubMed Web of Science ®Google Scholar
• Elder JW, Baraff SB, Gaschler WN, et al. Pulse oxygen saturation values in a healthy school-aged population. Pediatr Emerg Care. 2015;31:645–647.
   PubMed Web of Science ®Google Scholar
• Fouzas S, Priftis KN, Anthracopoulos MB. Pulse oximetry in pediatric practice. Pediatrics. 2011;128:740–752.
   PubMed Web of Science ®Google Scholar
• Zyoud SH, Awang R, Sulaiman SA, et al. An analysis of the length of hospital stay after acetaminophen overdose. Hum Exp Toxicol. 2011;30:550–559.
   PubMed Web of Science ®Google Scholar
• Hoffman RS. Understanding the limitations of retrospective analyses of poison center data. Clin Toxicol. 2007;45:943–945.
   PubMed Web of Science ®Google Scholar
• Zimmerman T, Beuhler MC, Kerns W. Is nurse interpretation of the ECG QRS width reliable? J Med Toxicol. 2012;8:140–144.
   PubMedGoogle Scholar
• Brown SM, Campbell SD, Crafford A, et al. P-glycoprotein is a major determinant of norbuprenorphine brain exposure and antinociception. J Pharmacol Exp Ther. 2012;343:53–61.
   PubMed Web of Science ®Google Scholar
• Alhaddad H, Cisternino S, Declèves X, et al. Respiratory toxicity of buprenorphine results from the blockage of P-glycoprotein-mediated efflux of norbuprenorphine at the blood–brain barrier in mice. Crit Care Med. 2012;40:3215–3223.
   PubMed Web of Science ®Google Scholar
• Lam J, Baello S, Iqbal M, et al. The ontogeny of P-glycoprotein in the developing human blood–brain barrier: implication for opioid toxicity in neonates. Pediatr Res. 2015;78:417–421.
   PubMed Web of Science ®Google Scholar
• Daood M, Tsai C, Ahdab-Barmada M, et al. ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS. Neuropediatrics. 2008;39:211–218.
   PubMed Web of Science ®Google Scholar
• Mégarbane B, Alhaddad H. P-glycoprotein should be considered as an additional factor contributing to opioid-induced respiratory depression in paediatrics: the buprenorphine example. Br J Anaesth. 2013;110:842
   PubMed Web of Science ®Google Scholar